摘要
目的：探讨珂立苏联合硫酸镁治疗新生儿肺动脉高压的临床疗效。方法选取2010年1月～2012年1月期间于我院确诊的新生儿肺动脉高压患者189例，在应用呼吸机进行机械通气的基础上给予珂立苏联合硫酸镁治疗，观察记录患儿治疗前后的症状表现，动脉血氧饱和度（SaO2）、氧分压（PaO2）和pH值等。结果所有189例患儿共痊愈121例，好转要求出院45例，无效20例（其中死亡9例），放弃治疗死亡3例（其中胎粪吸入综合征1例，窒息2例），珂立苏联合硫酸镁治疗总有效率为89.2%。结论珂立苏联合硫酸镁治疗新生儿肺动脉高压疗效显著，可以作为新生儿肺动脉高压的临床治疗措施，值得推广应用。
Objective To observe the clinical efficacy of Calsurf joint Magnesium sulfate in treatment of neonatal pulmonary hypertension.Methods 189 patients with pulmonary artery pressure from 2010, 1 to 2012, 1 in our hospital, who were given kelisu combined Magnesium sulfate for treatment based on the application of mechanical ventilation in ventilator, symptoms, arterial oxygen saturation （SaO2）,partial pressure of oxygen （PaO2）and pH etc were observed and recorded before and after treatment.Results 121 cases of 189 were cured,45 cases were improved and request to leave the hospital,20 cases （including 9 deaths） were invalid,3 cases giving up treatment of death （1 cases was meconium aspiration syndrome,2 cases were asphyxia）,the total effective rate of kelisu combined Magnesium sulfate for treatment was 89.2%. ConclusionKelisu combined with Magnesium sulfate has a significant effect in treatment of neonatal pulmonary hypertension curative which can be used as a clinical treatment measures of neonatal pulmonary hypertension,and is worthy of popularization and application.
出处
《中国医药科学》
2014年第13期70-71,91,共3页
China Medicine And Pharmacy
关键词
珂立苏
硫酸镁
新生儿肺动脉高压
Calsurf
Magnesium sulfate
Neonatal pulmonary hypertension
